ZURICH, Dec 20 () - Deals between pharmaceutical companies and Washington to reduce prices for medicines in the United States will likely push up the cost of new ​drugs in Switzerland, the CEO of ...

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer in exchange for tariff ...

The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as ...

Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to lower the cost of drugs and are working with the ...

M&A news last week featured Mirum Pharmaceuticals announcing plans to acquire fellow USA-based Bluejay Therapeutics and its ...

Swiss drugmaker Roche has emerged as a key supporter of the initiative. Its CEO, Thomas Schinecker, told Swiss media that adopting US-style reference pricing would likely raise the cost of newly ...

Swiss pharmaceutical firm Novartis said Thursday that it expects its Kisqali breast cancer treatment to be the next blockbuster drug within its portfolio, as it looks to shift reliance away from its ...

ZURICH (Reuters) -Swiss exports to the United States rebounded sharply in September, with pharmaceutical companies ramping up their shipments to get ahead of potential U.S. tariffs, government data ...

Swiss pharmaceutical giant Roche said Monday it is accelerating the development of its Wegovy rival weight loss drugs following promising early stage trial data. The company's two obesity drug ...

Tariff, tariff, tariff – that is the word on the streets right now, and the Swiss officials are also trying to make it make sense. Businesses and governments must continually adjust to new ...

Switzerland is proposing that its gold industry builds a refinery in the US or increases its processing capacity there as part of a plan to reduce US trade tariffs, according to two people familiar ...